The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice.
Blagaic. Alenka Boban AB; Blagaic. Vladimir V; Romic. Zeljko Z; Sikiric. Predrag P
Key Findings
- BPC‑157 (10 pg‑10 µg) given before or after a high‑dose alcohol injection reduced acute toxicity signs like anesthesia, hypothermia, and death in mice.
- When administered after stopping chronic alcohol exposure, BPC‑157 lessened withdrawal severity measured over 24 hours.
- The peptide protected stomach and liver tissue from alcohol‑induced lesions in both short‑term and long‑term drinking models.
Practical Outcomes
- For biohackers, BPC‑157 looks promising as a potential protectant against alcohol‑related organ damage and withdrawal, but the evidence is limited to mice. No human dosing guidelines exist, and the ultra‑low doses used in the study may not translate directly. If you experiment, start with the lowest available oral dose and monitor liver function, but treat this as experimental rather than a proven protocol.
Summary
In mice, the peptide BPC‑157 (a tiny 15‑amino‑acid chain) reduced damage to the stomach and liver caused by both a single big dose of alcohol and long‑term drinking. It also lessened alcohol‑withdrawal symptoms when given after the mice stopped drinking. The effects were seen at very tiny doses given by injection or by mouth.
Abstract
The stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, M.W.1419), which was promising in inflammatory bowel disease (PL-10, PLD-116, PL-14736, Pliva) trials, protects against both acute and chronic alcohol-induced lesions in stomach and liver, but also, given peripherally, affects various centrally mediated disturbances. Now, in male NMRI mice BPC 157 (10 pg intraperitoneally, 10 ng and 10 microg, intraperitoneally or intragastrically) (i) strongly opposed acute alcohol (4 g/kg intraperitoneally) intoxication (i.e., quickly produced and sustained anesthesia, hypothermia, increased ethanol blood values, 25% fatality, 90-min assessment period) given before or after ethanol, and (ii) when given after abrupt cessation of ethanol (at 0 or 3 or 7 h withdrawal time), attenuated withdrawal (assessed through 24 hours) after 20%-alcohol drinking (7.6 g/kg) through 13 days, with provocation on the 14th day.
Study Information
pubmed
2004
2004-09-24T00:00:00.000Z
10.1016/j.ejphar.2004.07.112